Dong T. Cheng

1 Hospital Blvd
Southport, QLD 4215, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Cost comparison between apixaban and low molecular weight heparin (LMWH) among venous thromboembolism (VTE) patients with cancer.

Cost comparison between apixaban and low molecular weight heparin (LMWH) among venous thromboembolism (VTE) patients with cancer.

Journal: Current medical research and opinion

Published: September 04, 2026

Plain language summary looking at the impact of increased patient out-of-pocket costs on stopping oral anticoagulant treatment among Medicare beneficiaries with atrial fibrillation treated with apixaban.

Plain language summary looking at the impact of increased patient out-of-pocket costs on stopping oral anticoagulant treatment among Medicare beneficiaries with atrial fibrillation treated with apixaban.

Journal: Current medical research and opinion

Published: May 26, 2026

Identification and Studies of Highly Potent and Selective Heterobifunctional Galectin‑3 Degraders.

Identification and Studies of Highly Potent and Selective Heterobifunctional Galectin‑3 Degraders.

Journal: ACS medicinal chemistry letters

Published: May 14, 2026

Discovery of Pyrazole-Containing RGD Mimics with Anti-Fibrotic Efficacy in the Unilateral Ureteral Obstruction Mouse Model.

Discovery of Pyrazole-Containing RGD Mimics with Anti-Fibrotic Efficacy in the Unilateral Ureteral Obstruction Mouse Model.

Journal: Journal of medicinal chemistry

Published: February 05, 2026

Micronutrient Depletion and Protein-Energy Malnutrition in Head and Neck Reconstructive Surgery.

Micronutrient Depletion and Protein-Energy Malnutrition in Head and Neck Reconstructive Surgery.

Journal: The Laryngoscope

Published: January 13, 2026

Impact of increased patient out-of-pocket costs on oral anticoagulant discontinuation among Medicare beneficiaries with atrial fibrillation treated with apixaban.

Impact of increased patient out-of-pocket costs on oral anticoagulant discontinuation among Medicare beneficiaries with atrial fibrillation treated with apixaban.

Journal: Current medical research and opinion

Published: November 06, 2025

Plain language summary of the direct oral anticoagulant switch study: effect of switching or continuing apixaban or rivaroxaban among people with non-valvular atrial fibrillation.

Plain language summary of the direct oral anticoagulant switch study: effect of switching or continuing apixaban or rivaroxaban among people with non-valvular atrial fibrillation.

Journal: Future cardiology

Published: August 20, 2025

Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.

Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.

Journal: Journal of comparative effectiveness research

Published: August 05, 2025

Geographic Variation in Persistence of Oral Anticoagulant Treatment Among Patients with Non-Valvular Atrial Fibrillation in the United States.

Geographic Variation in Persistence of Oral Anticoagulant Treatment Among Patients with Non-Valvular Atrial Fibrillation in the United States.

Journal: Journal of clinical medicine

Published: July 29, 2025

Demographic and Socio-Economic Disparities in the Outcomes Among Patients with NVAF Treated with Oral Anticoagulants: A Real-World Evaluation of Medicare Beneficiaries.

Demographic and Socio-Economic Disparities in the Outcomes Among Patients with NVAF Treated with Oral Anticoagulants: A Real-World Evaluation of Medicare Beneficiaries.

Journal: Journal of clinical medicine

Published: March 27, 2025

Geographic and Racial Variation in Oral Anticoagulant (OAC) Treatment Among Commercially Insured Patients with Non-valvular Atrial Fibrillation (NVAF) in the United States.

Geographic and Racial Variation in Oral Anticoagulant (OAC) Treatment Among Commercially Insured Patients with Non-valvular Atrial Fibrillation (NVAF) in the United States.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: March 03, 2025

Predictive criteria for oesophageal perforation in patients with pneumomediastinum: can invasive diagnostic modalities be avoided?

Predictive criteria for oesophageal perforation in patients with pneumomediastinum: can invasive diagnostic modalities be avoided?

Journal: Emergency medicine journal : EMJ

Published: February 18, 2025

Showing 1-12 of 48

Last Updated: 09/26/2026